A phase I trial evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of intravenously administered low-anticoagulant heparin (M6229) in critically ill sepsis patients
一项I期临床试验，旨在评估静脉注射低抗凝血肝素（M6229）在危重脓毒症患者中的安全性、耐受性、药代动力学和药效学。
期刊:Intensive Care Medicine Experimental
影响因子:
doi:10.1186/s40635-025-00790-4
van Mourik, Niels; van Amstel, Rombout B E; Slim, Marleen A; van Vught, Lonneke A; van der Poll, Tom; Huckriede, Joram; de Vries, Femke; de Kimpe, Sjef J; Crabbé, Raf; van Leeuwen, Simone J M; Ekhart, Peter F; Reutelingsperger, Chris P M; Nicolaes, Gerry A F; Vlaar, Alexander P J; Müller, Marcella C A
